Overview

A Clinical Study to Evaluate the Efficacy and Safety of Hemocoagulase Injection

Status:
Unknown status
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
This is a multi-centre, randomised, double blind, placebo controlled clinical study which is designed to evaluate the efficacy and safety of hemocoagulase in the treatment of moderate to severe hemoptysis.
Phase:
Phase 4
Details
Lead Sponsor:
Lee's Pharmaceutical Limited
Collaborator:
Zhaoke Pharmaceutical (Hefei) Company Limited
Treatments:
Thrombin